Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 77

Results For "Pharma"

4977 News Found

Operations disrupted at NATCO Pharma's Manali, Chennai factory
News | December 08, 2023

Operations disrupted at NATCO Pharma's Manali, Chennai factory

NATCO temporarily shut down the operations due to cyclone with flooding/water logging of the factory premises


AbelZeta Pharma, AstraZeneca to co-develop a novel GPC3 armored CAR-T therapy in China
News | December 08, 2023

AbelZeta Pharma, AstraZeneca to co-develop a novel GPC3 armored CAR-T therapy in China

C-CAR031 is based on a novel GPC3-targeting CAR-T (AZD5851) designed by AstraZeneca using their transforming growth factor-beta receptor II


Sun Pharmaceutical inks licensing agreement with Aclaris Therapeutics
News | December 06, 2023

Sun Pharmaceutical inks licensing agreement with Aclaris Therapeutics

The agreement includes an upfront payment of US$15 million, regulatory and commercial milestones, and royalties


Mankind Pharma's PetStar ties up with Ranbir Kapoor and Neetu Kapoor for new campaign
News | December 06, 2023

Mankind Pharma's PetStar ties up with Ranbir Kapoor and Neetu Kapoor for new campaign

The esteemed duo perfectly embody the brand's core values of family, love, and the special bond we share with our pets


Briefs: Shelter Pharma and GMM Pfaudler
News | December 06, 2023

Briefs: Shelter Pharma and GMM Pfaudler

GMM Pfaudler US completes acquisition of MixPro


Pradeep Chakravarty joins Alembic Pharmaceuticals as Head - Global Quality
People | December 05, 2023

Pradeep Chakravarty joins Alembic Pharmaceuticals as Head - Global Quality

Prior to joining Alembic, he was working with Lupin Limited for more than 11 years


AstraZeneca Pharma India receives permission from CDSCO to import new drug
Drug Approval | December 04, 2023

AstraZeneca Pharma India receives permission from CDSCO to import new drug

The receipt of this permission paves way for the launch of BREZTRI AEROSPHERE in India


Syngene concludes acquisition of biologics manufacturing facility from Stelis Biopharma
News | December 03, 2023

Syngene concludes acquisition of biologics manufacturing facility from Stelis Biopharma

The acquisition will add 20,000 litres of installed biologics drug substance manufacturing capacity for Syngene


AstraZeneca Pharma appoints Venkat Natarajan as Lead - Market Access
People | December 02, 2023

AstraZeneca Pharma appoints Venkat Natarajan as Lead - Market Access

Currently, Venkat is Lead – Market Access, India at Pfizer


Eugia Pharma receives USFDA approval for Budesonide Inhalation Suspension
Drug Approval | December 01, 2023

Eugia Pharma receives USFDA approval for Budesonide Inhalation Suspension

The product is expected to be launched in FY25